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A microRNA profile comparison between thoracic
aortic dissection and normal thoracic aorta indicates
the potential role of microRNAs in contributing to
thoracic aortic dissection pathogenesis
Mingfang Liao, MD, PhD, Sili Zou, MD, Jianfeng Weng, MD, Lewei Hou, MD, Lin Yang, MD,
Zhiqing Zhao, MD, Junmin Bao, MD, and Zaiping Jing, MD, Shanghai, China
Objectives: Our aim was to identify important microRNAs (miRNAs) that might play an important role in contributing
to aortic dissection by conducting a miRNA profile comparison between thoracic aortic dissection (TAD) and normal
thoracic aorta.
Methods: The differentially expressed miRNA profiles of the aortic tissue between TAD patients (n 6) and age-matched
donors without aortic diseases (NA; n  6) were analyzed by miRNA microarray. Quantitative reverse transcription
polymerase chain reaction (qRT-PCR) was further performed to verify the expression of 12 selected miRNAs with an
increased number of samples (TAD n 12; NA n 8). The potential targets of the differentially expressed miRNAs were
predicted using computational searches. Bioinformatic analyses of the predicted target genes (gene ontology, pathway
and network analysis) were done for further research. Additionally, Western blotting was performed to confirm the
bioinformatics findings.
Results: The miRNAmicroarray revealed differentially expressed miRNAs between the TAD and NA groups. In the TAD
group, 18 miRNAs were upregulated and 56 were downregulated (fold change >2, P < .01). qRT-PCR verified
statistically consistent expression of seven selected miRNAs with microarray analysis. Combined with our previous
proteomics study, target gene prediction revealed that some miRNAs reciprocally expressed with their targeted proteins.
Target gene-related pathway analysis showed a significant change in five pathways in the TAD group compared with the
NA group, especially the focal adhesion and the mitogen-activated protein kinase (MAPK) signaling pathways. By further
conducting miRNA gene network analysis, we found that the mir-29 and mir-30 families are likely to play a role in the
regulation of these two pathways, respectively.
Conclusions:Our results indicate thatmiRNAs expression profiles in aorticmedia fromTADwere significantly changed. These
results may provide important insights into TAD disease mechanisms. This study also suggests that the focal adhesion and
MAPK signaling pathways might play important roles in the pathogenesis of TAD. (J Vasc Surg 2011;53:1341-9.)
Clinical Relevance: TAD is a life-threatening disease with highmortality rates whose underlyingmechanism remains unclear.
The miRNAs usually negatively modulate gene expression at the post-transcriptional level. Studying both the disease-related
proteins and miRNAs in conjunction with the intermodulation between them can offer clarifications to the molecular
mechanism of the disease and provide more reliable molecular targets for prevention and treatment. Each possible miRNA
gene pair we identified in this study is a strong candidate for a major study aimed at definitively confirming the presence of
specific miRNA gene interactions, and providing possible molecular targets for prevention and treatment of the disease.
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May 20111342 Liao et almortality of TAD remains high. However, new advances in
the understanding of the pathogenesis of this serious illness
in conjunction with recent innovations in diagnostic and
treatment techniques may produce more favorable out-
comes in the future.
Many studies have been performed to explore the
pathogenesis of TAD. Most have provided important in-
sights into the disease mechanisms by focusing on the
genetic heterogeneity, clinical pathology, and hemody-
namics of TAD.2-4 We reported comparative proteomic
profiles of the aorta fromTADpatients in a previous study,5
and identified several differentially expressed proteins such
as 4 and a half LIM domains protein 1 (FHL1), osteogly-
cin, extracellular superoxide dismutase (SOD) and heat
shock protein 27 (HSP27), which may be involved in the
pathogenesis of TAD. However, the underlying mecha-
nism of TAD remains unclear.
The microRNAs (miRNAs) are a group of highly
conserved, small noncoding RNAs of 21 to 25nt, which
usually negatively modulate gene expression at the post-
transcriptional level by incomplete or complete comple-
mentary binding to target sequences within the 3= untrans-
lated region (3= UTR) of mRNA.6 Studying both the
disease-related proteins and miRNAs in conjunction with
the intermodulation between them may clarify the molec-
ular mechanism of the disease and provide more reliable
molecular targets for prevention and treatment.
There is an accumulating body of evidence that implicates
miRNAs’ involvement in a variety of biological processes such
as cell proliferation, differentiation, apoptosis, tumorigenesis,
etc.7 Aberrant and/or absent expression of miRNA is often
associated with pathophysiological disorders.8-10 Though the
research of miRNAs is still at an early stage in the field of
cardiovascular diseases, it is increasingly considered more im-
portant. Recent studies have mainly focused on the role of
miRNAs in cardiac development, cardiomyopathy, arrhyth-
mia, vascular endothelial function, etc. Though research fo-
cusing on the dominant cell of the aortic tunica media, the
vascular smooth muscle cell (VSMC), is relatively rare,11-15
there have been recent studies reporting new developments.
Cheng et al11 reported that mir-145 is a marker of VSMC
phenotype and plays an important role in rat carotid artery
neointimal lesion formation. Cordes et al12 reported that
Table I. Clinical characteristics of NA and TAD groups
NAa
(n  6)
Age (years) 39.5  6.2
Males/females 6/0
Maximal diameter (cm) 2.48  0.29
Atherosclerosis 2 (33.3%)
Hypertension 0 (0.0%)
Smoking 5 (83.3%)
NA, Without aortic diseases; TAD, thoracic aortic dissection.
aSample groups for miRNA microarray analysis.
bSample groups for qRT-PCR and Western blotting (including the samplesmiR-145 and miR-143 regulate smooth muscle cell fate and hlasticity. Elia et al13 discovered that the knockout of miR-
43 and -145 alters smooth muscle cell maintenance and
ascular homeostasis inmice, and verified thatmir145/143 in
scending aortic aneurysm was downregulated with quantita-
ive reverse transcription polymerase chain reaction (qRT-
CR). However, until now, little was known about the
iRNA profile and the potential role of miRNAs in the
athogenesis of aortic dissection.
Given the potential role of miRNAs in TAD, we pro-
led their expression in the aortic tissue of TAD and control
roup by microarray in this study. The differentially ex-
ressed miRNAs were then selected, validated, and sub-
ected to bioinformatic analyses, including gene ontology
nalysis, pathway analysis, and network analysis. Analyzing
he potential molecular markers and the possible relation-
hip between the differentially expressed proteins and
iRNAs in TAD will help give further insight into the
athogenesis of TAD.
ATERIALS AND METHODS
Aortic samples. Ascending aorta segments were col-
ected from TAD patients undergoing surgical repair (n 
2; mean age, 47.4 9.2 years) and organ donors (normal
ontrol, n 8; mean age, 40.9 6.7 years) without aortic
iseases. Six samples of each group were used for miRNA
icroarray and all the samples were used for PCR verifica-
ion and Western blotting. No significant difference in age
as found between the TAD and normal thoracic aortic
NA) groups (P  .05). Neither the TAD group nor
ormal control had any history of bicuspid aortic valve,
arfan syndrome, or any other aortic pathology. All pa-
ients had acute dissections with onset no earlier than 14
ays before surgery. All of them were confirmed to have
ebakey type I aortic dissection by preoperative examina-
ion or surgery. All the patients with hypertension (n  9)
ere taking antihypertensives for at least 3 months before
peration. Among them, five were taking calcium channel
lockers, four were taking beta-adrenergic blocking agents,
hree were taking diuretics, and three were taking
ngiotensin-converting enzyme inhibitors. Neither statins
or other relevant medications were taken. A detailed de-
cription of aortic samples is supplemented in Table I.
The study was approved by the ethics committee of our
ADa
 6)
NAb
(n  8)
TADb
(n  12)
 6.9 40.9  6.7 47.4  9.2
6/0 8/0 12/0
 1.17 2.36  0.29 5.55  1.11
66.7%) 3 (37.5%) 10 (83.3%)
83.3%) 0 (0.0%) 9 (75%)
66.7%) 5 (62.5%) 6 (50%)
roups).T
(n
47.5
5.56
4 (
5 (
4 (ospital, and all patients gave informed consent. All samples
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Volume 53, Number 5 Liao et al 1343used in this studywere prepared in parallel based on published
methods.5,16Media tissueswere sectioned into smaller sample
sizes and briefly stored at80°C until RNA extraction.
RNA extraction and miRNA microarray analysis.
Prefrozen aortic tissues (100 mg) were ground and ho-
mogenized, and total RNA was extracted as described
previously.17 The total RNAs were labeled with Hy3 dying
using the miRCURY Power labeling kit and hybridized on
the miRCURY LNA Array (version 11.0; Exiqon, Ved-
baek, Denmark), which contains more than 1700 capture
probes, covering all miRNAs annotated in miRBase 11.0.
The hybridization was performed according to the
miRCURY LNA array manual. GenePix 4000-B scanner
and GenePix Pro 6.0 software (Axon Instruments, Union
City, Calif) were used to scan images and for the analysis.
The intensity of the green signal was calculated after back-
ground subtraction and replicated spots on the same slide
had been averaged by obtaining a median intensity. After
normalization to the median, the average intensity of the
two groups was calculated in replicate.
miRNA analysis by qrt-Pcr. Parts of the differentially
expressed miRNAs between TAD andNAwere selected for
further verification. Expression of miRNAs was assayed
using stem-loop RT followed by PCR analysis as previously
described.18 We increased the number of samples to get a
more reliable result (Table I). cDNA synthesis was per-
formed on Gene Amp PCR System 9700 (Applied Biosys-
tems, Carlsbad, Calif). Real-time PCR was performed with
an ABI PRISM 7900 system (Applied Biosystems) in trip-
licate for each sample. The relative amount of miRNAs was
normalized against U6 snRNA, and the fold change for
each miRNA was calculated by the 2-deltadelta Ct method.19
The primers used for stem-loop RT-PCR are shown in
Supplemental Table I (online only).
Target gene prediction. Prediction of miRNA target
prediction can be performed by computational algorithms
due to their base-pairing rules betweenmiRNA andmRNA
target sites, location of binding sequences within the tar-
get’s 3=UTR, and conservation of target binding sequences
within related genomes. In our study, genes that were
predicted by TargetScan v5.1 (http://www.targetscan.org/),
Sanger (http://www.sanger.ac.uk/), Pictar (http://pictar.
bio.nyu.edu/), and Miranda v5 (http://miRNA.sanger.
ac.uk/) were regarded as potential targets of a certain
miRNA. We also used the algorithms in reverse to search
for the miRNAs that might target the genes previously
reported to be important in TAD.
Bioinformatic analysis of differentially expressed
miRNAs. Gene ontology (GO) analysis was applied in
order to organize genes into hierarchical categories and
uncover the miRNA gene regulatory network on the basis
of biological process, cellular component, and molecu-
lar function.20 We divided the differentially expressed
miRNAs into two groups (TAD upregulated and TAD
downregulated) and mapped these two groups to each
node of the GO database. The miRNAs corresponding to
every node were counted by GSEABase package on the R
statistic platform (http://www.r-project.org/). cWe also analyzed the potential target gene related
athways using GenMAPP v2.1 based on Kyoto Encyclo-
edia of Genes and Genomes (KEGG) pathway database.
he enrichment P value of the target genes involved in
very pathway was calculated. Afterward, we integrated the
egulatory interactions between the genes and miRNAs.
e analyzed two different interactions simultaneously: 1)
ata from KEGG database describing the relationship be-
ween genes, including enzyme-enzyme relation, protein-
rotein interaction, and gene expression interaction
KEGGSOAP software package (http://www.bioconductor.
rg/packages/2.4/bioc/html/KEGGSOAP.html) and
) protein-protein interactions verified by high-flux ex-
eriments (The MIPS Mammalian Protein-Protein In-
eraction Database: http://mips.helmholtz-muenchen.
e/proj/ppi/). Then, we integrated the results into the
ene network, and displayed the figure with the software
edusa21 (data not shown). After, we built certain
athway-related networks using predicted targets for the
iRNAs to identify critical miRNAs that might modulate
he pathways according to the miRNA degree.
Western blotting. In order to confirm the results of
ioinformatics analysis, we chose the mitogen-activated
rotein kinase (MAPK) pathway, which was found to be
nvolved in TAD according to the gene network analysis for
estern blotting verification. Western blotting analysis of
ortic protein extracts was performed to validate p38MAPK
nd HSP27 expression with standard procedures. A rabbit
nti-p38MAPK polyclonal antibody (1:1000; Cell Signaling
echnology, Danvers, Mass), mouse anti-HSP27 monoclonal
ntibody (1:1000; Cell Signaling Technology Biotechnology,
anta Cruz, Calif) and a horseradish peroxidase-labeled second-
ry antibody (SantaCruzBiotechnology)wereused in the study.
e also validated the protein expression of FHL1 and SOD1 in
heTAD tissue. The primary antibodies for FHL1 (0.1g/mL;
bcam, Cambridge, Mass) and SOD1 (0.2 g/mL; Abcam)
ere used in the study.
Statistical analysis. All the results were expressed as
ean standard deviation. Statistical analysis was done with
he Student t test for comparison of two groups in qRT-PCR
nd Western blotting, and analysis of variance for multiple
omparisons. In both cases, differences with P  .05 were
onsidered statistically significant. The statistically significance
f microarray result was analyzed by fold change and the
tudent t test. False discovery rate (FDR) was calculated to
orrect the P value. The threshold value we used to screen
ifferentially expressedmiRNAs is a fold change2.0or0.5
P .01, FDR .05). Then,we used diagonal linear discrim-
nant analysis (DLDA) for class prediction in the filtered
iRNA expression data as described previously.22,23 The
LDA analysis was performed with the “classify” function
mplemented in MATLAB Statistical toolbox (MathWorks,
atick, Mass). The performance of the predictor was tested
sing leave-one-out cross-validation method based on 2000
andompermutations.We also carried out 2000MonteCarlo
imulations to see if their error rate was less than what would
e expected by chance. Meanwhile, a hierarchical data set
lustering was performed on the miRNA expression profiling
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May 20111344 Liao et alwith cluster 3.0 and Treeview analysis (Stanford University,
Stanford, Calif), using the method as previously described.24
Principal component analysis was also performed to evaluate
the similarity between different samples.
RESULTS
miRNAs are aberrantly expressed in TAD com-
pared with NA. To study the potential biological functions
of miRNA in vascular disease, we determined the miRNA
expression profile in human aorta throughmiRNAmicroarray
analysis.Using themiRCURYLNAArray platform consisting
of all miRNAs annotated in miRBase, we first assessed the
miRNA expression profiles in the TAD and NA groups. The
expression profiles of 74miRNAs determined to be regulated
between TAD and NA separate samples into biologically
Fig 1. miRNA profiles differentiate the TAD group fro
whose expression was significantly altered (fold change
stands for the intensity of the signal. B, PCA shows that
profiles. C, In the scatter diagram, red spots stand for the
stand for the ones higher in the TAD group, and the bluinterpretable groups (Fig 1). Among these, 18 miRNAs were mdentified to be upregulatedmore than twofold inTADgroup
ompared with that in NA group, while 56 miRNAs were
ownregulated more than twofold (P  .01). The data of
hese miRNAs were showed in Supplemental Table II (online
nly). Furthermore, we evaluated the performance of the 74
iRNAs as a molecular classifier to distinguish TAD andNA.
sing DLDA and leave-one-out cross-validation, we found
hat 91.67% (11out of 12) of sampleswere correctly predicted
ith a sensitivity of 85.7% (6 out of 7) and specificity of 100%
5 out of 5). Based on 2000 Monte Carlo simulations, the P
alue is estimated to be less than 1/2000 (P .0005), which
ndicates that the proportion of the randompermutations that
ave a cross-validated error rate no greater than the cross-
alidated error rate with the real data, was .0005. These
esults indicate that the differentially expressed miRNAs
e NA group. A, Hierarchical clustering of 74 miRNAs
.01, FDR .05) in the TAD andNA groups. The color
AD and NA groups are separated well with the miRNA
NAs expressed higher in the NA group, the green ones
es with no significant change.m th
2, P
the T
miRight be able to predict the disease state of TAD. Twelve
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Volume 53, Number 5 Liao et al 1345miRNAs among these filtered ones were selected for qRT-
PCR verification, seven of which were validated to be signifi-
cantly different between the TAD and NA groups (P .05).
The other five show the expression tendency consistent with
the array result, but without statistical significance. As shown
in Fig 2, the levels of hsa-miR-183*, hsa-miR-433, hsa-miR-
553, hsa-miR-491-3p, hsa-miR-30c, and hsa-miR-338-5p
were upregulated in TAD compared with the NA group,
while hsa-miR-143, hsa-miR-145, hsa-miR-22, hsa-miR-24,
hsa-miR-93 and hsa-miR-768-5p showed an opposite expres-
sion pattern, in agreement with the results of microarray
hybridization (Supplemental Table II, online only).
Potential targets of the differentially expressed
miRNAs are revealed. Computational algorithms showed
that hsa-miR-491-3p and hsa-miR-22 might target some
TAD differentially expressed proteins related genes, and
hsa-miR-183*, hsa-miR-30c, hsa-miR-143, hsa-miR-
145 might target some cytoskeleton-associated protein-
related genes. The four pairs of reciprocally expressed
miRNA and protein were predicted at least by one of the
four algorithms, two of which were predicted by three of
Fig 2. Validation of selected microarray data by qRT-PC
relative amount of eachmiRNAwas normalized toU6 snR
is indicated by *P  .05. (A, Upregulated miRNAs in Tthe algorithms. The expression of FHL1, SOD1, tSP27, and p38MAPK in the aortic tissue was validated
y Western blotting (Fig 3). A previous comparative
icroarray study concerning gene expression in acute
tanford type A dissection showed the converse regula-
ion of several genes compared with that of the relevant
iRNAs in the TAD group25 (Table II).
MAPK signaling pathway and focal adhesion might
e regulated by miRNAs according to bioinformatics
nalyses. GO analysis showed that the high-enrichment
Os targeted by both overexpressed and underexpressed
iRNAs were cell communication, signal transduction,
NA metabolic process, transcription, cell differentiation,
tc. The pathway analyses revealed that there were seven
ifferent pathways corresponding to the target genes, five
f which were with an enrichment P .01 (Table III). This
nalysis showed a significant change of the focal adhesion
ndMAPK signaling pathway in the TAD group compared
ith the NA group.
hsa-miR-29 and hsa-miR-30 families might be
he key regulators of focal adhesion and MAPK
athway in TAD, respectively. The miRNA-gene in-
riplicate assays were done for each RNA sample and the
Statistically significant difference between TAD andNA
B, Downregulated miRNAs in TAD).R. T
NA.eraction networks related to the pathway we predicted
w
i
d
t
T
a
m
r
u
t
m
h
f
G
t
i
JOURNAL OF VASCULAR SURGERY
May 20111346 Liao et alpreviously are established in Fig 4. The downregulated
miRNAs hsa-miR-29a and hsa-miR-29c showed the
most target mRNAs both of 10 (degree 10) when focal
adhesion is concerned, while the downregulated hsa-
miR-30 family (except for hsa-miR-30c, which is up-
regulated) occupy an important position in the MAPK
pathway, with degrees from 3 to 7. The hsa-miR-29
family is predicted to target collagen-related genes
(COL11A1, COL1A2, COL2A1, COL3A1, COL4A1,
COL5A3, COL6A3, and COL4A6), which might play
an important role in the pathogenesis of TAD.
DISCUSSION
Aortic dissection results from a weakening of the arte-
rial wall and is characterized by the separation of aortic
media caused by the flow of extraluminal blood, which
creates a false lumen within the aortic wall layers. Even
though aortic aneurismal disease is often arbitrarily
Fig 3. Validation for the expression of HSP27 (A), p38
Western blotting. In the TAD group compared with NA
SOD1 are underexpressed.grouped with dissection, aortic dissection may exist alone pithout aortic aneurysm.26 The pathogenesis of this disease
s still vague, and the gene regulation involved in this
isease has been unclear until now.
Increasing evidence has confirmed miRNA to be one of
he most important factors controlling gene expression.
herefore, we evaluated the miRNA expression profile in the
ortic tissue of TAD patients to reveal the potential role of
iRNAs in the pathogenesis of TAD. Microarray techniques
evealed a set of differentially expressed miRNAs, with 18
pregulated and 56 downregulated miRNAs in TAD aortic
issue when compared to normal aortas. qRT-PCR of hsa-
iR-183*, hsa-miR-433, hsa-miR-553, hsa-miR-491-3p,
sa-miR-30c, hsa-miR-22, hsa-miR-143, and hsa-miR-145
urther validated the reliability of the microarray result.
In order to gain insight into the function of miRNAs,
O term and KEGG pathway annotation were applied to
heir target gene pool. KEGG annotation showed a signif-
cant change with the focal adhesion and MAPK signaling
K (B), FHL1 (C), and SOD1 (D) in the aortic tissue by
27 and p38MAPK are overexpressed, while FHL1 andMAP
, HSPathway in the TAD group compared with the NA group.
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Volume 53, Number 5 Liao et al 1347Further investigation of the miRNA-gene network of these
two pathways shows that the hsa-miR-29 and hsa-miR-30
family might be the key regulators of focal adhesion and
MAPK pathway, respectively.
A previous study showed that downregulation of miR-29
with anti-miRs in vitro and in vivo induces the expression of
collagens, and miR-29 acts as a regulator of cardiac fibrosis,27
another showed a significantly increased expression of aortic
collagen types I and III in TAD patients, which is likely to be
responsible for the compromised aortic distensibility and sys-
temic compliance.28 Our study first reveals that hsa-miR-29a
and hsa-miR-29c are underexpressed inTADwhen compared
with the NA group according to the microarray result, with a
significant change fold of 0.16 and0.22, respectively. Further-
more, these two miRNAs are predicted to target collagen-
related geneswith bioinformaticmeans. Thus, we come to the
speculation that the underexpression of hsa-miR-29a and
hsa-miR-29c may lead to the increased collagen deposition in
the aortic wall and contribute to the pathogenesis of TAD.
Mir-143/145 are reported to modulate cytoskeletal dy-
Table II. Differentially expressed miRNAs and computati
miRNA
Target
symbol Target common name
Hsa-miR-491-3p FHL1 Four and a half LIM domains 1
Hsa-miR-491-3p SOD1 Superoxide dismutase 1
Hsa-miR-491-3p TPM1 Tropomyosin alpha chain,
skeletal muscle
Hsa-miR-22 HSPB2 Heat shock 27-kDa protein 2
Hsa-miR-22 MAPK14 Mitogen-activated protein
kinase p38 alpha
Hsa-miR-22 OGN Osteoglycin
Hsa-miR-22 SOD2 Superoxide dismutase 2
Hsa-miR-22 TAGLN Smooth muscle protein
22-alpha/transgelin
Hsa-miR-183* FHL2 Four and a half LIM domains 2
Hsa-miR-183* IL-6 Interleukin-6
Hsa-miR-30c ACTN1 Actinin, alpha-1
Hsa-miR-30c ITGB3 Integrin, beta 3
Hsa-miR-143 ACTN1 Actinin, alpha-1
Hsa-miR-143 GSN Gelsolin
Hsa-miR-145 MMP11 Matrix metalloproteinase 11
Hsa-miR-145 TPM1 Tropomyosin alpha chain
aThe gene expression level in the TAD group was published in a previous st
al. Gene expression in acute Stanford type A dissection: a comparative micr
Table III. Target gene-related pathways
Term Count P value En
Focal adhesion 57 4.91E-06 1.
MAPK signaling pathway 65 9.72E-05 1.
MTOR signaling pathway 19 5.13E-04 2.
Wnt signaling pathway 40 9.35E-04 1.
Insulin signaling pathway 35 0.002688522 1.
Notch signaling pathway 15 0.011685325 2.
Adherens junction 20 0.019419186 1.
MAPK, Mitogen-activated protein kinase; NA, without aortic diseases; TAnamics and responsiveness of smooth muscle cells to injury.14 phey cooperatively target a network of transcription factors,
ncluding Klf4, myocardin, and Elk-1, to promote differenti-
tion and repress proliferation of smooth muscle cells.12 Loss
f miR-143 andmiR-145 expression induces structural mod-
fications of the aorta due to an incomplete differentiation of
SMCs.13 A previous study discovered that the transition of
SMCs from the contractile to the synthetic phenotype exists
n the media of TAD aorta,29 implying that VSMCs are
nderdifferentiated in TAD. Our study reveals for the first
ime that mir143/145 are underexpressed in TAD, which
ay help explain whyVSMCs are underdifferentiated in TAD
nd finally contribute to the aortic remodeling of TAD.How-
ver, this interpretation needs to be additionally validated in
urther studies.
Our study also revealed other differentially expressed
iRNAs in TADwhen compared with NA group which may
ave great importance in the pathogenesis of the disease.
sa-miR-491-3p is predicted to target FHL1, a cytoskeleton-
ssociated protein, and SOD1, an oxidative stress-associated
rotein, which are underexpressed in TAD aortic tissue
y predicted targets
nda TargetScan PicTar Sanger
TAD expression level
miRNA Protein Genea
s 1 2
s 1 2
s Yes 1 2
s Yes Yes 2 1 1
s Yes Yes 2 1
Yes Yes 2
s Yes 2 1
s Yes Yes Yes 2
s 1
s 1
Yes 1 2
s Yes Yes 1
s Yes 2
s Yes 2
s 2 1
s Yes 2
eis Muller BT, Modlich O, Drobinskaya I, Unay D, Huber R, Bojar H, et
study. J Transl Med 2006;4:29).
ent FDR (%)
Down count
(TAD  NA)
Up count
(TAD  NA)
3 0.006152864 50 15
591 0.121899126 59 15
665 0.641253007 16 7
066 1.166094013 36 14
935 3.320690566 32 7
039 13.7091162 12 8
79 21.80734655 17 7
racic aortic dissection.onall
Mira
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Ye
Yerichm
8015
5784
3431
6661
6427
0073
6998roved by Western blotting (Fig 3), while hsa-miR-491-3p is
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May 20111348 Liao et alreciprocally expressed. hsa-miR-22 is predicted to target
HSP27 and its upstream molecular p38MAPK, which are
validated to be overexpressed in TAD aortic tissue compared
with control group by Western blotting (Fig 3), while hsa-
miR-22 is underexpressed according to the microarray and
PCRresults. The regulationbetween thesemiRNA-genepairs
Fig 4. miRNA-gene interactionnetworks of focal adhesion
that are downregulated in TAD aortic tissue, green represen
show the inhibitory effect of miRNA on mRNA. Hsa-miR
targets mRNAs of 10 in focal adhesion (both degree 10) (A
showed the most targets mRNAs of 3 to 7 in the MAPK pneeds to be validated in the future studies. dIn conclusion, our study revealed for the first time the
iRNAs that differentially express in TAD when compared
ith the control group. Their regulation roles in the focal
dhesion and MAPK signaling pathways may be involved in
he pathogenesis of the disease. The lack of hsa-miR-29 may
ead to the increased collagendeposition and contribute to the
andMAPKpathway (B).Blue boxnodes representmiRNA
gulated ones, and red cycle nodes represent mRNA. Edges
family (hsa-miR-29a and hsa-miR-29c) showed the most
hsa-miR-30 family (hsa-miR-30e, -30a, -30d, -30b, -30c)
y (degrees 7, 5, 5, 3, 3, respectively; B).(A),
t upre
-29
), andisease. The underexpression of hsa-miR-143/145may affect
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Volume 53, Number 5 Liao et al 1349the VSMCs phenotype, thus, contributing to structural mod-
ifications of the aorta in TAD. The Hsa-miR-30 family may
have great importance in the MAPK pathway and contribute
to the disease, but confirmation and elucidation of this mech-
anism requires further study. Present results also point to
several exciting directions for future research. Each possible
miRNA-gene pair we identified is a strong candidate for a
major study to definitively confirm the presence of specific
miRNA-gene interactions, thus creating a more detailed pic-
ture of the pathogenesis of TAD.
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Gene
Annealing
temperature (°C) Number
U6 60 F: 5=GCTTCGGC
R: 5=CGCTTCAC
Hsa-miR-183* 60 GSP: 5=GGGTGA
R: 5=CAGTGCGT
Hsa-miR-491-3p 60 GSP: 5=TGCTTA
R: 5=TGCGTGTC
Hsa-miR-22 60 GSP: 5=GGTTAA
R: 5=CAGTGCGT
Hsa-miR-30c 60 GSP: 5=GGGGGT
R: 5=CAGTGCGT
Hsa-miR-433 60 GSP: 5=CAATATC
R: 5=CAGTGCGT
Hsa-miR-553 60 GSP: 5=GGGGAA
R: 5=CAGTGCGT
Hsa-miR-143 60 GSP: 5=GGGATG
R: 5=TGCGTGTC
Hsa-miR-145 60 GSP: 5=GGTCCA
R: 5=CAGTGCGT
Hsa-miR-93 60 GSP: 5=GGCAAA
R: 5=CAGTGCGT
Hsa-miR-338-5p 60 GSP: 5=GGGAAC
R: 5=CAGTGCGT
Hsa-miR-24 60 GSP: 5=GGTGGC
R: 5=CAGTGCGT
F, Forward primer; GSP, gene specific primer; R, reverse primer.
miRNA number and the sequence of a specific miRNA can be obtained froT-PCR
gene primer (5=¡ 3=) Accession no.
Product
size (bp)
AGCACATATACTAAAAT3’ K00784 89
GAATTTGCGTGTCAT3’
ATTACCGAAGGG3’ MIMAT0004560 64
GTCGTGGAGT3’
TGCAAGATTCCC3’ MIMAT0004765 61
GTGGAGTC3’
GCTGCCAGTTGAA3’ MIMAT0000077 66
GTCGTGGAGT3’
GTAAACATCCTAC3’ MIMAT0000244 68
GTCGTGGAGT3’
ATGATGGGCTCCT3’ MIMAT0001627 64
GTCGTGGAGT3’
AACGGTGAGATT3’ MIMAT0003216 65
GTCGTGGAGT3’
AGATGAAGCACT3’ MIMAT0000435 62
GTGGAGTC3’
GTTTTCCCAGG3’ MIMAT0000437 64
GTCGTGGAGT3’
GTGCTGTTCGTG3’ MIMAT0000093 65
GTCGTGGAGT3’
AATATCCTGGTGC3’ MIMAT0004701 65
GTCGTGGAGT3’
TCAGTTCAGCAG3’ MIMAT0000080 64
GTCGTGGAGT3
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May 20111349.e2 Liao et alSupplemental Table II (online only). The list of miRNAs identified in TAD and NA aortic tissues by microarray
miRNA TAD mean NA mean Fold change P value FDR
Upregulated
microRNAs
Hsa-miR-183* 31.37335929 1.485673612 21.11726226 .000124411 0.004293775
Hsa-miR-433 1.186781636 0.102242705 11.60749454 .004762721 0.03142462
Hsa-miR-553 5.481035418 0.762026599 7.192708792 .004916831 0.031971278
Hsa-miR-1284 21.01884015 3.040822673 6.912221595 .005245527 0.033351482
Hsa-miR-491-3p 1.19657323 0.242756108 4.929116875 .002359195 0.021915037
Hsa-miR-138-1* 4.5055059 1.04687553 4.303764651 .002986649 0.024529618
Hsa-miR-1247 0.134994411 0.033933907 3.978157014 .004722442 0.031312349
Hsa-miR-943 4.153248591 1.088255869 3.81642655 .006927085 0.037078991
Hsa-miR-300 5.004058419 1.500996137 3.333824981 .009581457 0.044471176
Hsa-miR-208b 0.545956493 0.175316606 3.114117397 .002694303 0.023702822
Hsa-miR-1321 7.346489681 2.464492871 2.98093363 .003132792 0.025099631
Hsa-miR-485-3p 1.547544337 0.528440874 2.92850991 .000718856 0.011421412
Hsa-miR-377* 0.385967764 0.136995141 2.817382868 .006280167 0.03563611
Hsa-miR-1285 10.031232 3.9556906 2.535899 .0013 0.0165071
Hsa-miR-30c 0.3307519 0.1447194 2.2854704 .0020862 0.0199956
Hsa-miR-488 0.909186 0.4033881 2.2538739 .0061619 0.0355724
Hsa-miR-891a 0.98323 0.4493717 2.1880105 .0009996 0.0137634
Hsa-miR-146b-3p 1.4625046 0.7176308 2.0379624 .0097224 0.0448274
Downregulated
microRNAs
Hsa-miR-320a 0.525726453 9.069254615 0.057967989 7.05798E-05 0.004121545
Hsa-miR-320b 0.616756438 8.589978517 0.071799532 8.17342E-05 0.004121545
Hsa-miR-140-3p 0.294044988 3.310834758 0.088812946 .000939122 0.013739763
Hsa-miR-320c 0.629675127 6.625227159 0.095042043 8.35029E-05 0.004121545
Hsa-miR-140-5p 0.202737519 1.739520704 0.11654792 .001172481 0.015321936
Hsa-miR-30a 0.110708572 0.750765774 0.147460867 3.32699E-05 0.003523353
Hsa-miR-130a 0.102573866 0.694078015 0.147784347 .000152025 0.004798772
Hsa-miR-133a 0.01339301 0.089922455 0.148939552 .000296034 0.00653216
Hsa-miR-133b 0.020561136 0.135120572 0.152168804 .000507642 0.008873846
Hsa-miR-29a 0.167410133 1.043216447 0.160474975 7.83633E-05 0.004121545
Hsa-miR-320d 0.838058946 5.090735157 0.164624346 .000111494 0.004293775
Hsa-miR-193a-3p 0.229309131 1.207345386 0.189928361 .001400579 0.017137994
Hsa-miR-100 0.051550574 0.269896895 0.191000991 .002366111 0.021915037
Hsa-miR-101 0.055599772 0.290061373 0.191682785 9.24674E-07 0.00124505
Hsa-miR-26a 0.218258565 1.121806768 0.194559857 .00021169 0.005537159
Hsa-miR-29c 0.056820479 0.261823135 0.217018557 .000114918 0.004293775
Hsa-miR-145 0.06117596 0.280827689 0.217841626 .00147531 0.017730065
Hsa-miR-28-5p 0.018209487 0.080656522 0.225765841 .003733714 0.027462181
Hsa-let-7g 0.128784601 0.558029077 0.230784749 7.67017E-05 0.004121545
Hsa-miR-30d 0.036344733 0.153206153 0.23722763 2.54415E-05 0.003523353
Hsa-miR-195 0.142905468 0.587155714 0.243385978 .000213917 0.005537159
Hsa-miR-886-5p 0.641176172 2.538021961 0.2526283 .004120077 0.029815181
Hsa-miR-22 0.620068798 2.326604984 0.26651228 8.01059E-05 0.004121545
Hsa-miR-17 0.113950821 0.410626276 0.277504942 .000225626 0.005621875
Hsa-miR-1246 5.86123801 20.61789628 0.284279149 .002559024 0.022931249
Hsa-miR-143 1.7248372 5.7487298 0.300038 .0025725 0.0229312
Hsa-miR-488* 0.0251964 0.0834621 0.3018902 .0003722 0.0074771
Hsa-miR-199a-5p 0.1310848 0.4260056 0.3077067 .0002612 0.0059597
Hsa-miR-93 0.1004026 0.3184046 0.3153301 .0006167 0.0102486
Hsa-miR-125b 0.1940142 0.6118313 0.3171041 .001354 0.0170112
Hsa-miR-922 0.1645587 0.4822948 0.3411994 .0012385 0.0158768
Hsa-miR-424 0.3035853 0.8835051 0.3436146 .000811 0.0124051
Hsa-miR-146a 0.0371656 0.107919 0.3443844 .0098372 0.0448406
Hsa-miR-151-3p 0.0250281 0.0714505 0.3502861 .000183 0.005473
Hsa-miR-24 1.164442 3.3178001 0.3509681 .0045683 0.0308989
Hsa-miR-296-5p 0.0321386 0.0901369 0.3565532 .0074908 0.0388374
Hsa-miR-876-3p 0.0463384 0.1287483 0.3599151 .0068384 0.037079
Hsa-miR-497 0.036013 0.0986243 0.3651529 .0015689 0.0185236
Hsa-miR-193a-5p 0.0291476 0.0793466 0.3673459 .0025932 0.0229631
Hsa-miR-30e 0.0341106 0.0910939 0.374455 6.276E-05 0.0041215
Hsa-miR-656 0.0350651 0.0909727 0.385447 .0009366 0.0137398
Hsa-miR-30b 0.0259872 0.0654413 0.3971069 .0009641 0.0137634
Hsa-miR-149* 22.16245 52.486509 0.4222504 .0018852 0.0196278
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miRNA TAD mean NA mean Fold change P value FDR
Hsa-miR-768-5p 0.3906338 0.9233181 0.423076 .0001457 0.0047842
Hsa-miR-625 1.0269226 2.3491452 0.4371473 .0024688 0.0226051
Hsa-miR-365 0.0356545 0.0801889 0.444631 .0087858 0.0420727
Hsa-miR-1227 0.0452885 0.1013676 0.4467747 .0008805 0.0133156
Hsa-miR-20a 0.0676638 0.1469384 0.4604908 .0014176 0.0171901
Hsa-miR-214 1.1157862 2.4003002 0.4648528 .0001677 0.0051316
Hsa-miR-744 2.8268482 6.0071576 0.47058 .0097248 0.0448274
Hsa-miR-15a 0.1144993 0.2412046 0.474698 .0001008 0.0042415
Hsa-miR-26b 0.9584308 1.9707744 0.4863219 .0020535 0.0199635
Hsa-miR-615-5p 0.0387533 0.0793987 0.4880846 .0013649 0.0170112
Hsa-miR-605 0.0345498 0.0705478 0.4897363 .0043165 0.0303421
Hsa-miR-10a* 0.1471986 0.2993711 0.4916928 .0002297 0.0056219
Hsa-miR-296-3p 0.2779882 0.5652418 0.4918041 .0057992 0.0346923
FDR, False discovery rate; NA, without aortic diseases; TAD, thoracic aortic dissection.
The list of miRNAs identified in TAD andNA aortic tissues with their mean expression values determined following global normalization and statistical analysis
using Student’s t test as described in theMaterials andMethods. Fold increase in TAD compared to NA is shown (increased expression twofold). Fold decrease
in TAD compared with NA is shown (decreased expression 0.5-fold). The P value and FDR was .01 and .05, respectively.
